Does the progression-free interval after primary chemotherapy predict survival after salvage chemotherapy in advanced and recurrent endometrial cancer? A gynecologic oncology group ancillary data analysis

Kathleen N. Moore, Chunqiao Tian, D. Scott McMeekin, J. Tate Thigpen, Marcus E. Randall, Holly H. Gallion

Research output: Contribution to journal › Article › peer-review

35 Citations (SciVal)

Fingerprint

Dive into the research topics of 'Does the progression-free interval after primary chemotherapy predict survival after salvage chemotherapy in advanced and recurrent endometrial cancer? A gynecologic oncology group ancillary data analysis'. Together they form a unique fingerprint.

Medicine and Dentistry